Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Equity (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Return on Equity for 6 consecutive years, with 0.77% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity fell 13.0% to 0.77% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.77%, a 13.0% decrease, with the full-year FY2025 number at 0.61%, down 7.0% from a year prior.
  • Return on Equity was 0.77% for Q4 2025 at Pliant Therapeutics, up from 0.83% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.26% in Q2 2023 to a low of 0.87% in Q2 2025.
  • A 5-year average of 0.5% and a median of 0.46% in 2021 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: crashed -50bps in 2021, then skyrocketed 42bps in 2023.
  • Pliant Therapeutics' Return on Equity stood at 0.46% in 2021, then grew by 18bps to 0.38% in 2022, then grew by 13bps to 0.33% in 2023, then plummeted by -96bps to 0.65% in 2024, then fell by -19bps to 0.77% in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Return on Equity are 0.77% (Q4 2025), 0.83% (Q3 2025), and 0.87% (Q2 2025).